Watson et al.[12] reported that CAXII was expressed in 75% of invasive breast carcinoma cases, and was significantly associated with a lower histological grade (P = 0.001), positive estrogen receptor status (P<0.01), and negative epidermal growth factor receptor overexpression (P<0.001). Here, CA12 is linked to invasive breast carcinoma.